These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24919375)

  • 21. How and why AIDS changed drug policy in Switzerland.
    Somaini B; Grob P
    J Public Health Policy; 2012 Aug; 33(3):317-24. PubMed ID: 22895501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility.
    Andresen MA; Boyd N
    Int J Drug Policy; 2010 Jan; 21(1):70-6. PubMed ID: 19423324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The implementation of overdose prevention sites as a novel and nimble response during an illegal drug overdose public health emergency.
    Wallace B; Pagan F; Pauly BB
    Int J Drug Policy; 2019 Apr; 66():64-72. PubMed ID: 30708237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Science, faith and AIDS: the battle over harm reduction.
    Wynia MK
    Am J Bioeth; 2005; 5(2):3-4. PubMed ID: 16036687
    [No Abstract]   [Full Text] [Related]  

  • 25. Harm reduction and needle exchange programmes.
    Bluthenthal RN; Kral AH; Lorvick J; Erringer EA; Edlin BR
    Lancet; 1998 Jun; 351(9118):1819-20. PubMed ID: 9635989
    [No Abstract]   [Full Text] [Related]  

  • 26. Harm reduction--from a conceptual framework to practical experience: the example of Germany.
    Michels II; Stöver H
    Subst Use Misuse; 2012; 47(8-9):910-22. PubMed ID: 22676562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Speaking and learning across disciplines in the harm reduction debate.
    Pollack HA
    Int J Drug Policy; 2023 Nov; 121():104108. PubMed ID: 37385918
    [No Abstract]   [Full Text] [Related]  

  • 28. Expanding supervised injection facilities across Canada: lessons from the Vancouver experience.
    Young S; Fairbairn N
    Can J Public Health; 2018 Apr; 109(2):227-230. PubMed ID: 29981039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guidelines for better harm reduction: evaluating implementation of best practice recommendations for needle and syringe programs (NSPs).
    Strike C; Watson TM; Lavigne P; Hopkins S; Shore R; Young D; Leonard L; Millson P
    Int J Drug Policy; 2011 Jan; 22(1):34-40. PubMed ID: 20413288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Supervised Inhalation Sites: Preventing Overdose and Reducing Health Inequities among People Who Use Drugs.
    Lu A; Kim C; Rosen JG; Thompson E; Tardif J; Welwean R; Park JN
    Subst Use Misuse; 2024; 59(4):520-526. PubMed ID: 38044494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Being realistic about benefits of supervised injecting facilities.
    Hall W; Kimber J
    Lancet; 2005 Jul 23-29; 366(9482):271-2. PubMed ID: 16039316
    [No Abstract]   [Full Text] [Related]  

  • 32. Community-acquired needle-stick injuries: rapid and safe retrieval of discarded needles is essential.
    Blenkharn JI
    Pediatrics; 2008 Dec; 122(6):1405; author reply 1405-6. PubMed ID: 19047264
    [No Abstract]   [Full Text] [Related]  

  • 33. Mobilizing Drug Consumption Rooms: inter-place networks and harm reduction drug policy.
    McCann E; Temenos C
    Health Place; 2015 Jan; 31():216-23. PubMed ID: 25576837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CLINICAL VIEW ON SUBSTANCE-INDUCED PSYCHOTIC SYMPTOMS IN A MEDICALLY SUPERVISED INJECTING ROOM: A DECADE OF EXPERIENCE.
    Palma-Álvarez RF; Daigre C; Ballabriga-Córdoba T; Monterde-Ochoa E; Sierra-Fortuny M; Cantillo M; Pelaez M; Castrillo E; Camañes L; Roncero C; Ramos-Quiroga JA; Grau-López L
    Actas Esp Psiquiatr; 2023 Jul; 51(4):188-191. PubMed ID: 37817739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measuring effectiveness of needle and syringe exchange programs for prevention of HIV among injecting drug users: Response to Amundsen.
    Maher L; Iversen J; Kaldor J
    Addiction; 2006 Dec; 101(12):1834-6. PubMed ID: 17156184
    [No Abstract]   [Full Text] [Related]  

  • 36. Syringe exchange.
    Jacobs R; Toynton P
    N J Med; 2003 Sep; 100(9 Suppl):55-9; quiz 79-80. PubMed ID: 14556605
    [No Abstract]   [Full Text] [Related]  

  • 37. [Harm reduction interventions in drug users: current situation and recommendations].
    Bosque-Prous M; Brugal MT
    Gac Sanit; 2016 Nov; 30 Suppl 1():99-105. PubMed ID: 27837802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The transition to harm reduction: understanding the role of non-governmental organisations in Malaysia.
    Narayanan S; Vicknasingam B; Robson NM
    Int J Drug Policy; 2011 Jul; 22(4):311-7. PubMed ID: 21300533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Communities launch needle exchange programs to curb HIV infection rates.
    Jee M
    J Am Health Policy; 1993; 3(5):55-7. PubMed ID: 10128278
    [No Abstract]   [Full Text] [Related]  

  • 40. Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003.
    Emmanuelli J; Desenclos JC
    Addiction; 2005 Nov; 100(11):1690-700. PubMed ID: 16277629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.